Secondary immunodeficiency is reported in most patients with hematological malignancies
such as chronic lymphocytic leukemia and multiple myeloma. The aim of our review was to …

Treatment standards for chronic lymphocytic leukemia (CLL) have been transformed with the
advent of effective inhibitors of B-cell receptor signaling such as ibrutinib–a first-in-class …

Natural killer (NK) cells are a major component of the anti-tumor immune response. NK cell
dysfunctions have been reported in various hematologic malignancies, including chronic …

Cancer pathogenesis involves the interplay of tumor-and microenvironment-derived stimuli.
Here we focused on the influence of an immunomodulatory cell type, myeloid-derived …

Immunotherapies, such as chimeric antigen receptor (CAR) T-cell therapy and bispecific
antibodies or T-cell engagers, have revolutionized the treatment landscape for various B-cell …

We report a coronavirus disease 2019 case with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised …

Background: In this study, the expression pattern of NKp30 and T cell immunoglobulin and
mucin domain-containing molecule-3 (Tim-3), as candidates for activating and inhibitory …

Skin cancer is the most common malignancy in humans with basal cell carcinoma
representing the majority of cases in the general population. The prevalence of skin cancer …

Secondary immunodeficiency is observed in all patients with chronic lymphocytic leukemia
(CLL) in varying degrees. The aim of the study was to review the available literature data on …

Simple Summary Skin cancers are the most diagnosed type of cancer worldwide.
Cutaneous squamous cell carcinoma—a type of skin cancer—usually affects older people …